TargetMol

CI 986

Product Code:
 
TAR-T30920
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T30920-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T30920-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T30920-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
CI 986 is a novel nonulcerogenic anti-inflammatory agent.
CAS:
130116-16-4
Formula:
C21H35N3O2S2
Molecular Weight:
425.65
Purity:
0.98
SMILES:
C[N+](C)(C)CCO.CC(C)(C)c1cc(cc(c1[O-])C(C)(C)C)-c1n[nH]c(=S)s1

References

1. Simard EP, Shiels MS, Bhatia K, Engels EA. Long-term cancer risk among people diagnosed with AIDS during childhood. Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):148-54. doi: 10.1158/1055-9965.EPI-11-0823. Epub 2011 Nov 8. PubMed PMID: 22068287; PubMed Central PMCID: PMC3312034. 2. Kalichman SC, Amaral CM, Stearns H, White D, Flanagan J, Pope H, Cherry C, Cain D, Eaton L, Kalichman MO. Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen Intern Med. 2007 Jul;22(7):1003-6. Epub 2007 Mar 28. PubMed PMID: 17390095; PubMed Central PMCID: PMC2219717. 3. G?k S, Ulker S, H?seyinov A, Hatip FB, Cinar MG, Evin? A. Role of leukotrienes on coronary vasoconstriction in isolated hearts of arthritic rats: effect of in vivo treatment with CI-986, a dual inhibitor of cyclooxygenase and lipoxygenase. Pharmacology. 2000 Jan;60(1):41-6. PubMed PMID: 10629442. 4. Wright CD, Kennedy JA, Kuipers PJ, Ferin MA. Stimulus-dependent effects of CI-986 on arachidonic acid metabolism by human neutrophils. Inflamm Res. 1995 Feb;44(2):74-8. PubMed PMID: 7655988.